The prevalence of high-risk human papillomavirus (HPV) DNA in cases of oral cavity squamous cell carcinoma (SCC) varies widely. The aim of this study is to investigate the frequency of high-risk HPV DNA in a large Brazilian cohort of patients with oral cavity SCC. Biopsy and resected frozen and formalin-fixed paraffin-embedded specimens of oral cavity SCC were available from 101 patients who were recruited at two Brazilian centres. Stringent measures with respect to case selection and prevention of sample contamination were adopted to ensure reliability of the data. Nested PCR using MY09/MY11 and GP5+/GP6+ as well as PGMY09/11 L1 consensus primers were performed to investigate the presence of HPV DNA in the tumours. HPV-positive cases were subjected to direct sequencing. Shapiro–Wilk and Student t test were used to evaluate data normality and to compare the means, respectively. Qualitative variables were analysed by logistic regression. Our results demonstrate that the frequency of high-risk HPV types in oral cavity SCC is very low and is less than 4%. All HPV-positive cases were HPV16. In addition, our results do not show a significant association between the tumour clinical features and the risk factors (tobacco, alcohol and HPV) for oral cavity SCC. In the current study, we observed an overlapping pattern of risk factors that are related to tumour development. This, along with a low frequency of high-risk HPV DNA, supports the findings that HPV is not involved in the genesis of oral cavity SCC in Brazilian population.
This prospective cohort study describes clinical, laboratory factors and virological factors associated with in-hospital mortality among 227 Intensive Care Unit (ICU) patients with SARS-CoV-2 infection admitted in Brazil during the pre-vaccination, pre-Omicron phase of the pandemic (September 2020 to March 2021). Clinical and laboratory data were extracted from medical records, and viral load was quantified by RT-qPCR Cycle threshold (Ct) values. Independent predictors of mortality were evaluated using multivariable Cox proportional hazards regression, and survival was analyzed with Kaplan-Meier curves. Non-survivors were significantly older (p < 0.001) and more likely to have hypertension (p = 0.014) and chronic respiratory disease (p = 0.042). At admission, they exhibited higher leukocyte counts (p = 0.001), D-dimer (p = 0.028), and creatinine levels (p = 0.001), as well as more frequent tracheal intubation (p < 0.001). During hospitalization, non-survivors showed persistently elevated leukocyte counts and developed more complications, including acute kidney injury, septic shock, and cardiac arrest (p < 0.001). Viral load was higher in non-survivors (p = 0.026) and among those requiring intubation (p = 0.042) or with cardiovascular disease (p = 0.016). In the multivariable Cox model, only creatinine at admission remained independently associated with mortality (HR = 1.18; 95% CI: 1.00-1.39; p = 0.049). Survival analysis showed reduced survival among patients aged ≥ 65-years (p = 0.004) and those with chronic respiratory disease (p = 0.029). This study integrates clinical, laboratory, and viral load data to detail the early COVID-19 severity and mortality patterns in a Brazilian ICU.
Background/Objectives: Head and neck squamous cell carcinoma (HNSCC) remains a global public health challenge with significant morbidity and mortality. Emerging epidemiological data indicate a rising global incidence of human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC). Serology for early HPV antigens has been highlighted as a relevant biomarker for HPV-associated OPSCC. This study aimed to determine the seroprevalence of HPV16 E6 antibodies in HNSCC patients in the state of Espírito Santo, Brazil. Methods: This is a prospective longitudinal cohort study in which 287 patients with HNSCC were enrolled, recruited from two oncology centers in Espírito Santo between 2011 and 2018, along with 68 cancer-free individuals. Serum samples were analyzed using the HPV16 E6 GST Capture ELISA assay. Statistical analysis was performed using SPSS. Binary logistic regression was employed to identify independent predictors of seropositivity. Results: The overall seroprevalence of HPV16 E6 antibodies was 7.3%. Seropositivity was observed in tumors of the oral cavity (6.2%) and oropharynx (13.3%). Patients with OPSCC demonstrated a significantly higher likelihood of seropositivity compared to those with tumors of the oral cavity, larynx, and hypopharynx (OR = 2.96, 95% CI: 1.21–7.28, p = 0.018). The highest frequency of HPV16 E6-positive cases occurred in tumors of the palatine tonsils (OR = 6.00; 95% CI: 1.58–22.89; p < 0.009). No seropositive cases were observed in hypopharyngeal or laryngeal tumors. Among patients with OPSCC and oral cavity squamous cell carcinoma (OCSCC), HPV16 E6 serostatus did not significantly correlate with sociodemographic, behavioral, or clinical tumor characteristics. Conclusions: Our findings reinforce the predilection of HPV-associated carcinogenesis for the oropharynx, more specifically in the palatine tonsils. In addition, this study highlights HPV16 E6 serology as a potential biomarker for HPV-driven OPSCC and underscores Brazil’s epidemiological heterogeneity, warranting standardized clinical validation.